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ARTICLE
Apoptotic signalling targets the post-endocytic
sorting machinery of the death receptor Fas/CD95
Shruti Sharma1,3, Antonio Carmona1,3, Agnieszka Skowronek1, Fangyan Yu1,2, Mark O. Collins 1,
Sindhu Naik 1, Claire M. Murzeau1, Pei-Li Tseng1 & Kai S. Erdmann 1
Fas plays a major role in regulating ligand-induced apoptosis in many cell types. It is well
known that several cancers demonstrate reduced cell surface levels of Fas and thus escape a
potential control system via ligand-induced apoptosis, although underlying mechanisms are
unclear. Here we report that the endosome associated trafﬁcking regulator 1 (ENTR1), con-
trols cell surface levels of Fas and Fas-mediated apoptotic signalling. ENTR1 regulates, via
binding to the coiled coil domain protein Dysbindin, the delivery of Fas from endosomes to
lysosomes thereby controlling termination of Fas signal transduction. We demonstrate that
ENTR1 is cleaved during Fas-induced apoptosis in a caspase-dependent manner revealing an
unexpected interplay of apoptotic signalling and regulation of endolysosomal trafﬁcking
resulting in a positive feedback signalling-loop. Our data provide insights into the molecular
mechanism of Fas post-endocytic trafﬁcking and signalling, opening possible explanations on
how cancer cells regulate cell surface levels of death receptors.
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as (CD95/Apo-1) is a member of the tumour necrosis
receptor family and the prototype of a death receptor, which
can cause ligand-induced apoptosis via activation of a pro-
tease cascade1. Fas exists as a preassociated trimer at the plasma
membrane2,3. Ligand binding to Fas induces a conformational
change allowing its cytoplasmic death domain to engage with
other proteins, which leads to the formation of the so-called
death-inducing signalling complex (DISC)1,4. Key to the forma-
tion of DISC is the association of Fas with the Fas associated
death domain protein FADD, which itself is associated with the
proteases procaspase-8 and 101,4–6. Procaspase-8/10 are cleaved
and activated upon activation of Fas in an autoproteolytic process
initiating a protease cascade involving other caspases (e.g. 3 or 6)
further downstream leading eventually to apoptosis7–9. It has
been shown that membrane trafﬁcking of the death receptor plays
an important role in Fas apoptotic signalling and that efﬁcient
formation of DISC takes place at the level of endosomes and thus
requires the endocytosis of Fas6. Furthermore, depending on cell
type and context, non-apoptotic signalling pathways such as the
activation of transcription factor NF- κB can also be activated
upon ligand binding to Fas10.
Physiologically, Fas plays a crucial role in the regulation of
peripheral immune tolerance as well as in lymphoid home-
ostasis11. However, it also plays an important role in tumour
progression. The role of Fas in cancer is complex and anti-
tumour activities as well as tumour-promoting activities have
been reported for the Fas/Fas-ligand system11. It is known that
during tumour progression cancer cells undergo a number of
changes. One of the early changes observed is increased resistance
to apoptosis, which allows cancer cells to escape important con-
trol mechanisms12. In line with this is the observation that many
cancer cells acquire resistance to Fas-induced apoptosis. This
resistance can be achieved either by upregulation of anti-
apoptotic proteins13, by acquiring mutations in the Fas gene
itself14 or by downregulation of Fas15. Downregulation of Fas
takes place by two main mechanisms, which are not mutually
exclusive. One possibility is the downregulation of total Fas
protein levels, another possibility is to regulate the availability of
the receptor at the cell surface16–20. Thus, molecular mechanisms
and molecular players regulating cell surface levels of Fas are of
great interest. One such molecular player is the protein tyrosine
phosphatase PTPN13 (also known as FAP-1, PTPL1 or PTP-
BAS), which has been identiﬁed as a negative regulator of Fas cell
surface levels and Fas-induced apoptosis16,17,21,22. PTPN13
interacts directly with Fas21,23 and high expression levels of
PTPN13 inversely correlate with Fas cell surface levels16–18,24.
The microRNA mir-200c, which is often downregulated in early
stages of cancer, confers sensitivity to Fas-induced apoptosis via
targeting PTPN1325. We have recently shown that PTPN13 forms
a complex with the endosome associated trafﬁcking regulator
ENTR1, previously named SDCCAG3 (serologically deﬁned
colon cancer antigen-3)26. ENTR1 is an endosomal protein
localised to early and recycling endosomes26, which can associate
with the retromer component VPS35, and which plays a role in
cilia formation27–29. ENTR1 was originally identiﬁed as an anti-
gen in serum derived from colon cancer patients30. Subsequently,
it was identiﬁed in a screen for proteins regulating sensitivity to
tumour necrosis factor induced apoptosis31, however the under-
lying mechanism for this remained unclear.
Here we show that ENTR1 is a negative regulator of Fas cell
surface levels and Fas-induced apoptosis. We demonstrate that
ENTR1 is important for endolysosomal sorting of Fas. Moreover,
we show that ENTR1 is cleaved during Fas-induced apoptosis
revealing a positive feedback loop in apoptotic signalling. Our
data provide mechanistic insights into how membrane trafﬁcking
regulates sensitivity to Fas-induced apoptosis.
Results
Depletion of ENTR1 increases Fas cell surface levels. Recently
we identiﬁed ENTR1 as a binding partner for the protein tyrosine
phosphatase PTPN1326. PTPN13 is a known inhibitor of Fas-
induced apoptosis and negatively regulates Fas cell surface levels
by an unknown mechanism16. Given the tight interaction of
ENTR1 with PTPN13 we tested whether depletion of ENTR1
expression levels also changes Fas cell surface levels. To address
this question, we analysed Fas cell surface levels in HeLa cells
using immunoﬂuorescence microscopy upon siRNA mediated
depletion of ENTR1. We observed a signiﬁcant increase in
immunoﬂuorescence of Fas at the plasma membrane (Fig. 1a, b).
Furthermore, we conﬁrmed increased Fas surface levels upon
ENTR1 depletion biochemically using surface biotinylation fol-
lowed by anti-Fas western blotting. The increase was speciﬁc for
Fas because, by contrast, we did not observe such changes for
other housekeeping and cell surface signalling receptors such as
the transferrin receptor, the epidermal growth factor (EGF)
receptor or N-Cadherin (Fig. 1c, d). Furthermore, transfection of
the siRNAs did not have any effect on the mRNA levels of Fas as
measured by quantitative PCR (Supplementary Fig. 1). The
increase in surface Fas was reﬂected in a trend towards increased
levels of total Fas, which was signiﬁcant for siRNA 3 (Fig. 1d).
Next, we used ﬂuorescence ﬂow cytometry to measure Fas cell
surface levels upon ENTR1 depletion and conﬁrmed our ﬁndings
above (Supplementary Fig. 2). Further experiments showed that
increased Fas surface expression levels could be returned to con-
trol levels upon transfection of the corresponding siRNA resistant
ENTR1 expression construct for all three siRNAs applied (Fig. 1e,
f). We also conﬁrmed our ﬁndings in another cell line (the human
colon carcinoma cell line HCT116). In particular we observed here
a signiﬁcant increase in cell surface and total Fas expression levels
following ENTR1 siRNA treatment (Supplementary Fig. 3a–d).
Our data together strongly suggest that increased cell surface levels
of Fas depend on decreased ENTR1 expression levels. In line with
this is also our ﬁnding that increasing ENTR1 expression levels by
transfecting a GFP-ENTR1 expression construct correlates with
decreasing Fas cell surface levels in HeLa cells (Fig. 1g).
Regulation of Fas cell surface levels requires PTPN13. PTPN13
binds directly to Fas via its PDZ2 domain and is a known
negative regulator of Fas cell surface expression16,21; using two
different siRNAs we could conﬁrm that lowering PTPN13 levels
correlates with increased Fas cell surface expression also in HeLa
cells (Fig. 2a, b). In order to test whether interaction with
PTPN13 is important for ENTR1 to regulate Fas cell surface levels
we tested two ENTR1 point mutations, P167A and E171A, which
we had previously identiﬁed to abolish interaction with the FERM
domain of PTPN1326. Here we demonstrate using co-
immunoprecipitation experiments that these point mutations
also abolish interaction with full-length PTPN13 (Fig. 2c). In
order to test whether interaction with PTPN13 is important for
ENTR1 function, we performed rescue experiments measuring
Fas cell surface levels. HeLa cells were depleted of endogenous
ENTR1 and transfected with siRNA resistant expression con-
structs for wild-type ENTR1, ENTR1-P167 or ENTR1-E171A.
Whereas transfection with wild-type ENTR-1 lead to a full rescue
of Fas cell surface expression levels, we could not observe any
rescue effect with the mutant ENTR1 constructs (Fig. 2d). This
result strongly suggests that the formation of a PTPN13/ENTR1
protein complex is required to regulate Fas surface expression
levels.
Fas co-localises with ENTR1 and PTPN13. In order to under-
stand the molecular mechanism by which depletion of ENTR1
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Fig. 1 Surface levels of Fas receptors are increased upon silencing ENTR1. a Immunoﬂuorescence analysis of cell surface levels of Fas receptors upon ENTR1
no.2 and control knock-down in HeLa cells. Non-permeabilised HeLa cells were stained with Anti-Fas (CH-11) followed by Alexa 594 conjugated secondary
antibody staining. Images were obtained using a confocal microscope. Scale bar represents 5 µm. b Quantitative analysis of CTCF (corrected total cell
ﬂuorescence) represented as scatter plot with bars. Data were analysed by unpaired Student’s t-test, n= 3, **(p < 0.05), p value= 0.0073, error bars
represent ± s.e.m. c Immunoblot analysis of biotinylated cell surface fraction and total lysate of HeLa cells treated with three independent siRNA against
ENTR1 and control. Fas receptors were detected using anti-Fas (C-20) antibody; endogenous levels of other mentioned receptors were detected using their
speciﬁc antibodies; the arrow indicates non-speciﬁc (ns) bands; ß-tubulin was used as a loading control. d Quantitative analysis of cell surface levels of the
indicated receptors represented as bar graphs. On x-axis, ‘C’ stands for control siRNA and 1–3 stands for the three siRNAs against ENTR1. The y-axis
represents relative abundance of receptors expressed as a percentage when control is 100%. The quantiﬁcation shows mean of at least three independent
experiments (n= 3), error bars represent ± s.e.m; one-way ANOVA test, p-value; **< 0.05; p= 0.0340 for Fas. e Immunoblot analysis of surface levels of
Fas upon transfection with ENTR1 siRNA alone or co-transfection with siRNA and siRNA resistant ENTR1 constructs (labelled as Rescue 1–3) in HeLa cells.
Uncropped blots are shown in supplementary Fig. 11. f Quantiﬁcation of surface levels of Fas receptors normalised to ß-tubulin and expressed as a
percentage where control is 100%. Data was collected form three independent experiments (n= 3, One way ANOVA, *p < 0.05, p= 0.045, ns-not
signiﬁcant). Error bars represent ± s.e.m. g Flow cytometry analysis of surface abundance of Fas in HeLa cells upon GFP-ENTR1 overexpression.
Quantiﬁcation of the ﬂow cytometry analysis of Fas levels expressed as a percentage where GFP-transfected HeLa cells control is 100%. Bar graphs
represent the mean of the Alexa Fluor 488 nm median intensities from three independent experiments (n= 3), student t-test, error bars represent ± s.e.m
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elevates Fas levels, we ﬁrst analysed whether both proteins co-
localise within the cell. We have previously demonstrated that
ENTR1 localises to early/recycling endosomes suggesting a
potential role in membrane trafﬁcking26. We could not observe
signiﬁcant co-localisation of Fas and ENTR1 under non-stimulated
conditions, where most Fas appeared to be localised to the plasma
membrane and ENTR1 localised to intracellular punctae. However,
following stimulation of Fas with the agonistic antibody CH11 we
observed co-localisation of ENTR1 and Fas in punctate structures
as early as ﬁve minutes after stimulation in line with a co-
localisation of both proteins at endosomes (Fig. 3a, b). We also
observed co-localisation of Fas and PTPN13 in early endosome
antigen-1 positive punctates after stimulation of Fas (Fig. 3c, d,
Supplementary Fig. 4). Interestingly, whereas ENTR1 appears to be
constitutively localised to endosomes we only observed PTPN13 at
endosomes after Fas stimulation. Together this suggests that Fas
co-localises with ENTR1 and PTPN13 in early endosomes.
Depletion of ENTR1 correlates with delayed Fas degradation.
Increased cell surface expression levels of Fas could be due to
impaired endocytosis upon ENTR1 depletion. To test this pos-
sibility HeLa cells were transfected with siRNA targeting ENTR1
or control siRNA and endocytosis was monitored by ﬂuorescence
ﬂow cytometry after addition of CH11. There was no difference in
the kinetics of Fas endocytosis (measured as % of remaining Fas
at the cell surface after stimulation) in ENTR1 depleted cells
versus non-depleted cells suggesting that impaired endocytosis
does not account for the increase in cell surface levels upon
ENTR1 knock-down (Fig. 3e, f). In order to investigate any
changes in degradation kinetics of Fas we generated HCT116 cells
lacking ENTR1 using the CRISPR/Cas9 system (Fig. 4a, Supple-
mentary Fig. 8c). Wild-type and ENTR1 knock-out cells were
stimulated with CH11 for different times and the amount of Fas
was measured by Western-blotting. Whereas there was a clear
decline of Fas expression levels over time in wild-type HCT116
cells there was only a minor degradation of Fas observable in cells
lacking expression of ENTR1 (Fig. 4b, c). Furthermore, Fas
degradation could be blocked by leupeptin indicating lysosomal
degradation (Supplementary Fig. 5c). Similar results were also
found by downregulating ENTR1 using siRNA (see supplemen-
tary Fig. 5a, b). In contrast ENTR1 KO appears not to affect EGF
receptor degradation (Supplementary Fig. 7f, g). In summary our
data show that decreased ENTR1 expression levels correlate with
impaired Fas degradation.
Depletion of ENTR1 impaires transport of Fas to lysosomes.
Our observation that Fas degradation is delayed in ENTR1 KO cells
together with our ﬁnding that Fas and ENTR1 co-localise at
endosomes upon activation prompted us to investigate the endo-
lysosomal transport route and kinetics of Fas in more detail. Under
control conditions Fas is efﬁciently transported to lysosomes within
30min after Fas activation as demonstrated by co-localisation with
the late endosomal/lysosomal marker Lamp-1. However, in ENTR1
depleted cells, transport to lysosomes was signiﬁcantly impaired,
which is reﬂected in a reduced overlap coefﬁcient and reduced
Pearson´s correlation coefﬁcient (Fig. 4d, e). Interestingly, we made
a similar observation for non-stimulated Fas by performing an
antibody-feeding experiment using the non-agonistic anti-Fas
a b
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Fig. 2 ENTR1 requires binding to PTPN13 to regulate Fas cell surface levels. a Flow cytometry analysis of surface abundance of Fas in HeLa cells upon
PTPN13 knock-down. Shift of the peaks towards the right in all the samples as compared to the control indicates increased Alexa 488 intensity.
b Quantiﬁcation of the ﬂow cytometry analysis of Fas receptor levels expressed as a percentage relative control siRNA transfected cells. Bar graphs
represent the mean of the Alexa Fluor 488 nm median intensities (n= 3), three independent experiments, one way ANOVA. c Interaction of wild-type and
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blotting. d Flow cytometry analysis of Fas surface levels upon ENTR1 knock-down and rescue with aforementioned ENTR1 constructs. Bar graphs represent
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**p < 0.01, error bars represent ± SEM
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antibody DX-2 (Supplementary Fig. 6). These observations open
the possibility that transport of Fas from early endosomes to
lysosomes might be impaired. This was indeed the case as we
observed a decrease in co-localisation with Lamp-1 whereas there
was a concomitant signiﬁcant increase in co-localisation of Fas with
early endosome marker EEA1 in ENTR1 depleted cells compared
to control siRNA transfected cells after 30min of Fas activation
(Fig. 4f, g). In summary our data are in line with an impairment of
Fas to transit properly from the early endosomal compartment to
the lysosomal compartment.
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Fig. 3 Internalised Fas co-localises with ENTR1 and PTPN13 positive endosomes. a Immunoﬂuorescence analyses of co-localisation between Fas (green)
and ENTR1 (red). Fas was surface labelled with anti-Fas (CH-11) antibody (1 µg/ml) and were allowed to internalise for the indicated time points. Cropped
inset panels show examples of non-existent (0min) or existent co-localised particles. Images were acquired from a confocal microscope. Scale bars
represent 5 µm. b Quantiﬁcation of co-localisation between internalised FasR and ENTR1 (calculated using Mander’s overlap coefﬁcient R). Data was
analysed from ﬁve cells (for 0, and 30min) and eight cells (for 5, and 15 min time points) using Tukey’s multiple comparison tests, *p < 0.05, ***p < 0.01.
c Immunoﬂuorescence analysis of co-localisation between PTPN13 and Fas receptors. HeLa cells were stimulated with 1 μg/ml of anti-Fas (CH-11) antibody
(green) for the indicated time points. Cells were ﬁxed and stained for PTPN13 (red). Scale bar represents 5 μm. d Quantiﬁcation of co-localisation observed
in c. Pearson’s correlation coefﬁcient was calculated using JACoP tool in image J. Data represents average from three independent experiments (N= 3)
form at least (n > 30 cells). Student’s t-test, **p < 0.05, error bars represent ± s.e.m. e Flow cytometry analysis of internalisation of Fas induced upon
activation with anti-Fas (CH-11) antibody (1 µg/ml) for various time points. Relative amount of Fas receptors remaining on the cell surface was expressed
as a percentage where 0min was 100% in control treated HeLa cells. Data was collected from three independent experiments (n= 3) and analysed using
Tukey’s multiple comparisons tests, error bars represent ± s.e.m. f Representative histograms showing surface population of Fas after 0, 5 or 30min of
internalisation
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Fig. 4 ENTR1 knock-out cells show delayed degradation of Fas. a Western blot validation of ENTR1 knock-out in HCT-116 cell line generated by CRISPR-
Cas9. b Immunoblot analysis of the kinetics of degradation of endogenous Fas activated by agonistic anti-Fas (CH-11) antibody (500 ng/ml) in the
presence of cycloheximide (150 µg/ml) for the indicated time points. ß-tubulin was used as a loading control. c Relative receptor abundance expressed as a
percentage where 0min is 100% in wild-type or ENTR1 knock-out HCT-116 cells, respectively. Data was collected from three independent experiments
(n= 3) and analysed by multiple comparisons test, *p < 0.05, error bars represent ± SEM. d, f Immunoﬂuorescence analysis of sub-cellular localisation of
Fas receptors in HeLa cells upon stimulation with agonistic anti-Fas (CH-11) antibody (1 µg/ml) in the presence of Leupeptin (100 nM) for the indicated
time points. Upon internalisation, Fas receptors (green) co-localised with Lamp-1 positive vesicles (red) in control siRNA treated cells in contrast with
ENTR1 no.2 siRNA treated cells after 30min of antibody chase. Additionally, Fas receptors in control cells (green) did not co-localise with EEA-1 (red)
substantially as compared to the ENTR1 depleted cells after 30min of antibody chase. Images were acquired using a confocal microscope. Scale bar
represents 5 µm. e, g Quantiﬁcation of the extent of correlation (Pearson’s correlation coefﬁcient, PCC) and co-localisation (Mander’s overlap coefﬁcient
R) between Fas receptors and endosomal markers such as Lamp-1 and EEA-1. Co-localisation analysis was performed on confocal cross-sections using
JACoP (Just another co-localisation plugin) in ImageJ. Data was collected from three independent experiments n= 3, t-test, **p < 0.01, ***p < 0.001, error
bars represent ± s.e.m
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ENTR1 impairs sorting of Fas into intraluminal vesicles. Fol-
lowing internalisation, the canonical endolysosomal route for
transmembrane proteins is their transfer from the limiting
endosomal membrane into intraluminal vesicles of multivesicular
bodies. For many receptor-mediated signalling systems this is the
point where signal transduction is irreversibly shut off32,33. In
order to test whether this step might be affected by ENTR1
depletion we transfected HeLa cells with constitutively active GFP-
Rab5, which promotes the formation of enlarged endosomes34 and
thus facilitates the detection of Fas in the limiting membrane and
within the lumen of multivesicular bodies. This method has been
used previously to analyse transfer of other cargos from the lim-
iting membrane into the lumen of multivesicular bodies35. HeLa
cells were treated with control or ENTR1 siRNA for 72 h. Fas
receptors were stimulated with CH11 and examined for their
intracellular localisation by confocal microscopy. After 2 h of sti-
mulation, Fas was present mostly inside the lumen of enlarged
vesicles positive for Fas under control conditions. In contrast, in
ENTR1 depleted cells, Fas localised predominantly to the limiting
membranes of enlarged endosomes, where it appeared to localise
to speciﬁc subdomains, however we also observed some enlarged
endosomes with luminal Fas (Fig. 5a). In order to quantify the
distribution of Fas across the enlarged endosomes, a line scale
analysis was performed on confocal cross-sections as described
before36. A representative line scan analysis of a confocal cross-
section is shown in Fig. 5b, demonstrating the reduced luminal Fas
ﬂuorescence in ENTR1 depleted cells compared to control siRNA
transfected cells. The effect was further quantiﬁed by analysing the
middle ﬂuorescence of more than 100 individual enlarged
endosomes from three independent experiments (Fig. 5c). In
contrast we did not see any effect on the translocation of the EGF-
receptor into the lumen of MVBs, or the transferrin receptor,
which is mainly recycled to the plasma membrane (Supplementary
Fig 7a–d). This is also in line with our ﬁndings that EGF-receptor
degradation kinetics is unchanged in ENTR1 KO cells (Supple-
mentary Fig. 7e–g). In a second approach, we also analysed
potential defects in intraluminal sorting of Fas upon depletion of
ENTR1 with ‘super-resolution’ structured illumination micro-
scopy (SIM) combined with three dimensional modelling (3D).
We repeated the experiment described above but analyzed Fas
localisation in enlarged vesicles using SIM instead of confocal
imaging. Instead of seeing a diffuse distribution of Fas within the
lumen of the enlarged endosomes, SIM allowed us to resolve a
distinct luminal punctate localisation of Fas, likely representing
luminal vesicles. This is further corroborated by 3D modelling of
the enlarged vesicles, where Fas appears to localise to spherical
stuctures within the lumen under control conditions whereas in
ENTR1 depeted cells it is absent from the lumen but appeared in
the limiting endosomal membrane instead (Fig. 5d, e). In sum-
mary these results suggest that the delayed degradation of Fas is
due to an impaired transfer of Fas from the endosomal limiting
membrane to intraluminal vesicles.
Enhanced recycling increases Fas cell surface expression. It has
previously been observed that cargo accumulation at the level of
early endosomes can lead to enhanced recycling37–39. We tested
two main recycling pathways depending either on the small
GTPases Rab11 or Rab440,41. Using dominant negative Rab11 or
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the Rab11 binding domain of the Rab coupling protein (RCP) to
block Rab11-dependent recycling42 we observed that increased
Fas cell surface expression in ENTR1 depeleted cells can be
completely rescued (Fig. 6a). In contrast blocking the Rab4
dependent recycling route did not affect Fas cell surface expres-
sion (Fig. 6b). We conclude that the observed increased Fas
surface espression levels are due to enhanced Rab11-dependent
recycling.
ENTR1 is connected to the endolysosomal sorting machinery.
Recently, two independent proteomic studies have suggested that
ENTR1 forms a complex with the protein Dysbindin43,44. Dys-
bindin interacts directly with hepatocyte growth factor regualted
tyrosine kinase substrate (HRS or ESCRT-0)45,46, a component of
the ESCRT-complex, which is mainly responsible for sorting
cargo from the endosomal limiting membrane into intraluminal
vesicles. Furthermore, Dysbindin together with HRS regulates the
sorting of several G-protein coupled receptors to lysosomes and
into intraluminal vesicles, respectively36,45. Thus, the interaction
of ENTR1 and Dysbindin could provide a potential molecular
link between ENTR1 and the endosomal sorting machinery. To
test whether ENTR1 interacts with Dysbindin we applied a GST
pull down assay and conﬁrmed in line with previous proteomic
results that Dysbindin interacts with a fusion protein of GST and
ENTR1 but not with GST alone or GST-VAMP3, another coiled
coil containing protein (Fig. 7a). Dysbindin has also been
described as an obligatory component of BLOC-1 (biogenesis of
lysosome-related organelles-1 complex)47,48. Interestingly, we did
not ﬁnd any Pallidin, another obligatory component of BLOC-1,
in the pull-downs, suggesting that ENTR1 does not bind to the
canonical BLOC-1 complex. Furthermore, we could also
demonstrate interaction of ENTR1 and Dysbindin using co-
immunoprecipitation (Fig. 7b). To add further evidence that
binding of ENTR1 to Dysbindin is important for Fas sorting, we
performed rescue experiments using a mutant version of ENTR1
with signiﬁcantly reduced binding to Dysbindin. In binding site
mapping experiments we could demonstrate that an ENTR1
version lacking the last c-terminal 16 amino acids almost com-
pletely abolishes interaction with Dysbindin (Fig. 7c). We could
not observe any rescue expressing the mutant version of ENTR1
with reduced Dysbindin binding whereas wild-type ENTR1 could
rescue Fas cell surface levels (Fig. 7d). Next we tested whether
depletion of Dysbindin displays a similar phenotype with respect
to Fas localisation and trafﬁcking as observed after depletion of
ENTR1. Using ﬂuorescence ﬂow cytometry we observed also
increased Fas surface levels after Dysbindin depletion (Fig. 8a–c).
This increase was not further elevated upon simultaneous knock-
down of Dysbindin and ENTR1 as expected if both proteins act
mechanistically together (Fig. 8b). Interestingly, we also observed
increased Fas surface levels after HRS depletion (Fig. 8a, b).
Altogether, this opens the possibility that Dysbindin and HRS in
concert with ENTR1 regulate sorting of Fas into the lumen of
multivesicular bodies. To test this hypothesis we repeated the
experiments described above, analysing translocation of Fas from
the limiting endosomal membrane into intraluminal vesicles after
depletion of Dysbindin or after depletion of HRS, respectively. In
line with our hypothesis we observed in both cases impaired
translocation of Fas into the lumen of MVBs (Fig. 8d, e), however
we see also some endosomes with luminal Fas. Thus, our data
support the idea that ENTR1 regulates Fas sorting into intra-
luminal vesicles and to lysosomes via connecting to Dysbindin
and ESCRT-0.
Depletion of ENTR1 enhances Fas induced apoptosis. As
described above, knock-down of ENTR1 elevates cell surface
levels of Fas. To test whether this increase also correlates with
enhanced Fas-mediated apoptosis we incubated HeLa cells,
transfected with siRNA targeting ENTR1 or control siRNA, with
CH11 and monitored the extent of apoptosis. We observed a
signiﬁcant increase in non-viable cells in HeLa cells treated with
siRNA targeting ENTR1 compared to control siRNA treated cells.
This effect was strictly dependent on CH11 concentration
(Fig. 9a).
Fas is known to activate a signalling cascade which leads to
proteolytic activation of procaspase 8 and 3. Thus we tested
whether activation of caspase 8 and caspase 3 was also affected by
ENTR1 depletion. Activation of caspase 8 can be monitored by
Western-blotting via the appearance of the proteolytically cleaved
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active 18 kDa version of caspase 8 (in addition to a partially
cleaved version of 43/41 kDa). Caspase 3 can be monitored by
immunoﬂuorescence using an antibody speciﬁcally recognising
activated caspase 3. In line with increased surface expression levels
of Fas and increased rate of apoptosis we observed enhanced Fas-
mediated signalling as measured by activation of caspase 8
(Fig. 9b, c). We could also conﬁrm enhanced activation of caspase
8 and elevated Fas induced apoptosis in ENTR1 depleted HCT116
cells (Supplementary Fig. 3e–h). Finally, to demonstrate that this is
not only speciﬁc for CH11 as an agonistic trigger, we also
demonstrated increased apoptosis rates measuring caspase 3
activation in ENTR1 depleted cells treated with a soluble version
of the natural Fas-ligand (SuperFas-ligand) (Fig. 9d, e). In line
with our proposed model we also detected increased apoptosis
rates after knocking down of Dysbindin or HRS (Fig. 9f).
As demonstrated above we were able to rescue Fas cell surface
expression to wild-type levels in an ENTR1 depleted background
by blocking recycling using dominant negative Rab11 (Fig. 6a).
We have repeated this experiment and measured the apoptosis
rate. Surprisingly we observed only a partial rescue although we
were able to rescue cell surface expression completely (Figs. 6a,
9g). This suggests that increased cell surface levels are likely not
the only mechanism for the observed enhanced apoptosis.
ENTR1 is cleaved during Fas-induced apoptosis. A recent
report suggested that ENTR1 is a substrate for caspase 649, an
effector protease, which can be activated downstream of caspase 8
activation50. This ﬁnding opened the possibility that ENTR1
could be cleaved during Fas-mediated apoptosis as caspase 8 and
caspase 6 are activated after Fas activation51. To facilitate detec-
tion of potential Fas cleavage products of ENTR1 we transfected
HeLa cells with a Myc-tagged ENTR1 expression construct and
monitored its expression levels after induction of apoptosis. We
observed that the band of full-length Myc-ENTR1 became weaker
over time; in parallel we noticed the appearance of a shorter band
at around 35 kDa. This band did not appear upon adding CH11
together with the pan-caspase inhibitor z-Vad-FMK suggesting
that ENTR1 is cleaved in a caspase-dependent manner (Fig. 10a).
We also observed a cleavage product of similar size for endo-
genous ENTR1 after stimulation with CH11 (Supplementary
Fig. 9a). We performed a similar experiment in the presence of
more speciﬁc caspase inhibitors and observed signiﬁcant reduc-
tion of cleavage upon addition of inhibitors speciﬁc for caspase 6
or caspase 8. In contrast we could not see any inhibitory effect
with inhibitors for caspase 1 or caspase 3 (Supplementary
Fig. 9b), suggesting that caspase 6 and 8 contribute to the cleavage
of ENTR1 either directly or indirectly.
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Cleavage–resistant ENTR1 and its anti-apoptotic activity. Our
ﬁnding that a negative regulator of Fas cell surface levels like
ENTR1 is targeted by Fas apoptotic signalling has major
mechanistic implications as cleavage of ENTR1 could enhance
Fas apoptotic signalling similar as described above for the knock-
down of ENTR1. To investigate this further we mapped the
caspase cleavage site in ENTR1. ENTR1 has two major splicing
variants and to avoid missing any cleavage sites we decided to test
the longest splicing variant in our cleavage assays. We tagged
ENTR1 N-terminal with a Myc-tag and C-terminal with a Flag-
tag. Upon induction of apoptosis we could observe two cleavage
products, one was recognised by anti-myc antibody (at around
40 kDa) and one was recognised with anti-Flag antibody (at
around 27 kDa) (Fig. 10b and supplementary Fig. 9b). The
molecular weight of both fragments together is roughly equal to
the 65 kDa, which is what we observed for the double-tagged
ENTR1 protein suggesting that there is only a single caspase
cleavage site. Taking into account the molecular weights of the
cleavage fragments we identiﬁed potential cleavage sites based on
previously identiﬁed caspase cleavage sites in other proteins52. In
each of these sites we mutated the conserved aspartate to alanine;
in total we tested ﬁve different mutants in our apoptosis assay and
identiﬁed a single cleavage site at position amino acid 236
(Fig. 10b). LC-MS/MS analysis of a tryptic digest of the 27 kDa
band from immunoprecipitations of Myc-ENTR1-Flag conﬁrmed
cleavage at aspartate 236 by identiﬁcation of a semi-tryptic pep-
tide C-terminal to the cleavage site (supplementary Fig. 9c, d). All
rescue experiments above have been performed with splicing
variant 2, which is the 13 amino acid shorter variant of ENTR1.
To be consistent we introduced the same point mutation into
splicing variant 2 (D213A) and conﬁrmed that this leads to
caspase-resistance (Fig. 10c). Next, we tested the ability of this
mutant to rescue enhanced apoptosis in an ENTR1 knock-out
background. We generated HeLa cells lacking ENTR1 using
CRISPR/Cas9, which demonstrated as expected increased Fas cell
surface levels and enhanced sensitivity to Fas induced apoptosis
(Fig. 10d and supplementary Fig. 8d). We rescued enhanced
apoptosis by transfecting either wild-type ENTR1 or caspase-
resistant D213A ENTR1. As expected wild-type ENTR1 was able
to rescue the enhanced apoptosis, however caspase-resistant
ENTR1 was signiﬁcantly more effective in rescuing apoptosis
compared to wild-type ENTR1 (Fig. 10d). This result suggests
that blocking caspase-induced cleavage of ENTR1 reduces Fas
apoptotic signalling.
ENTR1/PTPN13/Fas expression levels in colon cancer tissue.
We have shown previously that ENTR1 expression is upregulated
in colon cancer tissue26. This prompted us to investigate
expression levels of ENTR1, PTPN13 and Fas in colon cancer
samples. We conﬁrmed our previous ﬁnding that ENTR1 is
upregulated in colon cancer tumours compared to non-tumorous
tissue, similarly we also observed elevated PTPN13 expression in
colon cancer tissue samples, whereas Fas expression was down-
regulated (Supplementary Fig. 10a–d). Interestingly, when com-
paring the expression of ENTR1/PTPN13 with Fas a signiﬁcant
proportion of colon cancer samples exhibit upregulated ENTR1
or PTPN13 and concomitantly downregulation of Fas expression
levels. 78% of the colon cancer samples with elevated ENTR1 and
73% of the colon cancer samples with elevated PTPN13 showed
downregulation of Fas expression (Supplementary Fig. 10e and f).
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This is in line with our ﬁndings that ENTR1 and PTPN13 are
important for sorting Fas for lysosomal degradation.
Discussion
In this study we identiﬁed the endosome associated trafﬁcking
regulator 1 (ENTR1) as a negative regulator of Fas cell surface
levels and Fas-induced apoptosis. We provide evidence that
ENTR1 is an important player of Fas endocytic trafﬁcking reg-
ulating Fas degradation by contributing to the sorting of Fas into
intraluminal vesicles of multivesicular bodies and thereby shut-
ting down Fas-dependent signal transduction. Furthermore, we
show that ENTR1 is cleaved during Fas-induced apoptosis
revealing a positive feedback loop of apoptotic signalling.
A key mechanism of cells to regulate responsiveness to parti-
cular ligands is by regulating cell surface levels of their
corresponding plasma membrane receptors and altered receptor
recycling can be part of disease mechanism53,54. We show here
that depletion of ENTR1 correlates with enhanced sensitivity to
Fas induced apoptosis. This is of particular importance, because
several cancer cells express low surface levels of Fas and thereby
escaping potential Fas induced apoptosis, however the underlying
molecular mechanism is often unclear16,17,19,20,22,55. Here we
present evidence for a role of ENTR1 and the multi-PDZ domain
protein PTPN13 in post-endocytic sorting of Fas to lysosomes.
We could not detect any effect of ENTR1 depletion at the step of
internalisation of Fas, which is in line with our previous ﬁnding
that ENTR1 localises to early and recycling endosomes26. How-
ever, we observed signiﬁcant impairment in the transition of Fas
from the early endosomal compartment to lysosomes. Similar
observations have been made before if cargo cannot enter
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intraluminal vesicles of MVBs. In such cases cargo remains in the
limiting endosomal membrane and cannot enter the lysosomal
compartment36,45,56. The main machinery regulating sorting of
cargo and formation of intraluminal vesicles are the ESCRT
complexes (0–IV)57,58. Several recent studies show a role for
Dysbindin in cargo delivery to lysosomes. Dysbindin forms a
complex with HRS and is important for post-endocytic sorting of
the G-protein coupled D2 dopamine receptor45. Furthermore,
Dysbindin forms also a complex with the G-protein Gαs and the
G-protein coupled receptor associated binding protein-1
(GASP1) regulating the post-endocytic trafﬁcking of a variety of
receptors including the chemokine receptor type 4 (CXCR4)36.
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Moreover, it was shown that Dysbindin is important for the entry
of CXCR4 into intraluminal vesicles36. Finally, depletion of
Dysbindin correlated with increased cell surface levels of CXCR4
and delayed degradation kinetics, very similar to what we have
observed for Fas after ENTR1 depletion. We show here that
ENTR1 interacts with Dysbindin and that this interaction is
important to regulate Fas cell surface levels. We also show that
depletion of Dysbindin leads to impaired translocation of Fas into
intraluminal vesicles of multivesicular bodies, increased Fas cell
surface levels and enhanced sensitivity to Fas induced apoptosis.
Taken together, this strongly suggests that ENTR1 regulates
sorting of Fas into intraluminal vesicles via the Dysbindin-HRS
axis. Our ﬁnding that depletion of HRS also increased Fas cell
surface levels and impaired endo-lysosomal sorting of Fas further
supports this. Dysbindin is a well-established component of
BLOC-1, which is implicated in intracellular protein trafﬁcking
and in the biogenesis of specialised organelles of the endo-
lysosomal system59,60. Our data point however to a second role of
Dysbindin likely independent of BLOC-1 in regulating cargo
transport into intraluminal vesicles. In line with this is our
observation that we could not ﬁnd Pallidin, which is another
obligatory BLOC-1 component, in ENTR1 pulldowns. Dysbindin
found in complex with ENTR1 represents likely a minor fraction
of total Dysbindin as most Dysbindin appears to cofractionate
with BLOC-1 in cells.
In summary, we propose a model where ENTR1 binds to Fas
via PTPN13 and connects to the ESCRT machinery via Dysbin-
din regulating post-endocytic sorting of Fas. In this model,
increased Fas cell surface expression is explained by the accu-
mulation of Fas at early endosomes and increased Rab11-
dependent recycling (Fig. 10e). Interestingly, increased recycling
has also been demonstrated in Dysbindin knock-out cells for the
dopamine D2 receptor45.
The endosomal compartment can serve as a major site for Fas-
mediated DISC formation and caspase-8 activation and Fas
internalisation is a major requirement for Fas-mediated apoptosis
in type I cells, cells which rely mainly on the extrinsic apoptosis
pathway without major involvement of the mitochondrial-
dependent apoptosis pathway4–6,50. The longer retention time
of Fas in the endosomal compartment observed after ENTR1
depletion is likely to contribute to enhanced apoptotic signalling
in ENTR1 depleted cells.
A number of proteins involved in intracellular trafﬁcking have
been shown to be substrates for caspases52. Here we show that
ENTR1 is a target for caspase-mediated cleavage after Fas acti-
vation. Together with our ENTR1 depletion results described
above, this suggests that proteolytic decrease of endogenous
ENTR1 protein impairs Fas degradation and increases apoptotic
signalling which will in turn increase caspase mediated cleavage
of ENTR1 and other downstream targets resulting in a positive
feedback loop of apoptotic signalling (Fig. 10e). As predicted by
our model we could observe enhanced anti-apoptotic activity with
a caspase-resistant version of ENTR1 compared to wild-
type ENTR1.
Finally, we have established here that ENTR1 and PTPN13 act
together to regulate Fas cell surface levels. This gives also deeper
insights into the mechanism how PTPN13 can regulate Fas
sensitivity in cancer. Previously, it has been noted that there is a
negative correlation between PTPN13 expression and Fas
induced apoptosis in cancer cell lines16,22,24,55,61–63 and in colon
cancer in vivo64,65. Furthermore, a recent study demonstrates that
uncoupling binding of Fas to PTPN13 by adding a peptide
derived from the PDZ binding motif of Fas restores Fas sensitivity
and decreased the growth of colon cancer xenografts in a mouse
cancer model65.
Our identiﬁcation of ENTR1 as a negative regulator of Fas-
mediated apoptosis has revealed insights into key aspects of the
endolysosomal sorting of Fas and how this regulates sensitivity to
Fas-induced apoptosis; however further investigations are neces-
sary to fully understand the complex interplay of Fas membrane
trafﬁcking and its signal transduction.
Methods
Antibodies and reagents. The following antibodies were used in this study:
ENTR1 (159691AP, 1:300 for IF) Proteintech, Manchester, UK; ENTR1
(HPA029303, 1:250 for IB), ß-tubulin (T4062, 1:5000 for IB), AntiFlag M2 (1:1000
for IB) Sigma‐Aldrich, England; Fas (C‐20, 1:500 for IB), N‐Cadherin (13A9, 1:500
for IB), rabbit anti-c-Myc (A-14, 1:100 for IB), rabbit anti-Fas (C-20, 1:500 IB),
rabbit anti-FAP1 (H-300, 1:500 for WB), goat anti‐EEA1 (N19, 1:100 for IF) Santa
Cruz (USA). Anti‐Fas clone CH11 (1:500 for IF and FC) Millipore and anti‐Fas
clone DX‐2 (1:500 for FC) Biolegend (USA). CD71 (D7G9X) XP (1:2000 for IB),
EGF (2232, 1:1000 for IB), rabbit anti‐EEA‐1 (C45B10, 1:300 for IF), anti‐HA (6E2,
1:1000 for IB), anti-Caspase 8 (1C12, 1:1000 for IB), anti-cleaved caspase 3
(Asp175, 1:400 for IF), anti-HRS (14346, 1:1000 for IB) Cell signalling (USA). Anti-
Dysbindin (ab124967, 1:1000 for IB), mouse anti-pallidin (ab169037, 1:500 for IB),
rabbit anti-Lamp‐1 (1: 800 for IF) Abcam (Cambridge, UK). Alexa 594 conjugated.
Transferrin Invitrogen and anti-CD261/TRAILR1 FITC conjugated (clone DR4‐
02) Life technologies. Rabbit anti-PTPN13 (NB100-56139, 1:500 for IF; 1:1000 for
IHC) from Novus Bio. Rabbit anti-GFP was a kind gift from Andrew Peden,
University of Shefﬁeld (1:2000 for IB). Caspase Family Inhibitor Set (K107) was
acquired from BioVision Inc.; Super Fas Ligand (sFasL) from Enzo Life Sciences
and GFP-Trap®_A from ChromoTek GmbH (Planegg-Martinsried, Germany).
Cell Culture, DNA and transfection. HeLa and HCT116 cells were from Sigma-
Aldrich. Cells were cultured and maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) high glucose (Invitrogen) supplemented with L‐glutamine, 10%
Fetal bovine serum (Invitrogen), 1% penicillin and streptomycin (Invitrogen) at 37
°C under 5% CO2. Full length‐ ENTR1 was from Origene (Rockville, MD, USA).
ENTR1 constructs were subcloned into pcDNA3 vector (Invitrogen, Darmstadt,
Germany) harbouring an N-terminal EGFP. Full length ENTR-1 was subcloned
into a pGEX-6-P1-GST vector (GE Healthcare, München). ENTR1 P167A and
E171A mutants and ENTR1 caspase cleavage mutants were generated by site-
directed mutagenesis (Quick change II XL by Agilent technologies). pGEX h-
VAMP3, Rab5 (Q79L)EGFP and RBD-GFP66 constructs were a kind gift of
Dr Andrew Peden. Rab11 wt-GFP, Rab4a wt-GFP and Rab4a S22N-GFP constructs
Fig. 10 ENTR1 is cleaved during Fas induced apoptosis. a Overexpressed ENTR1-myc (55 kDa) was cleaved upon activation of Fas-mediated apoptotic
signalling to a produce a 35–40 kDa band after 3 h of treatment (indicated by an arrow) with anti-Fas (CH-11) and cycloheximide. Cleavage of Caspase 8
(p18) was also observed only upon activation with anti-Fas (CH-11). Myc-ENTR1 was not cleaved upon activation by cycloheximide only or b in the
presence of pan-caspase inhibitor (z-vad-FMK). b ENTR1 is cleaved by caspase at position aa236 (isoform1) into two fragments (indicated by arrows).
Myc- and ﬂag-tagged ENTR1 mutants D179A, D181A, D234A and D236A were created by site-directed mutagenesis using D251A mutant as a template.
c Immunoblot showing equal protein expression of the ENTR1 rescue constructs (includes a cartoon of the ENTR1 caspase resistant construct). Cleaved
ENTR1 product indicated with an arrow. beta-tubulin was used as a loading control. d A caspase resistant ENTR1 has increased anti-apoptotic activity
compared to wild-type ENTR1. Quantiﬁcation of the immunoﬂuorescence analysis of activated caspase 3 in CH11 treated wild-type HeLa cells or ENTR1
knock-out cells transfected as indicated in the graph. Relative percentage of apoptosis is shown and HeLa wild-type GFP-transfected cells is considered as
100%. Only GFP positive cells were included in the quantiﬁcation. Data was collected from three independent experiments (n= 3), One-way ANOVA was
performed, **p < 0.01, ***p < 0.001, error bars represent ± SEM. e Working model for endolysosomal sorting of Fas via the ENTR1/PTPN13 complex and
Dysbindin. Impaired sorting of Fas into intraluminal vesicles leads to increased recycling and elevated Fas cell surface expression. Caspase dependent
cleavage of ENTR1 contributes to a positive feedback apoptotic signalling loop (PM= plasma membrane)
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were a kind gift from Prof Elizabeth Smythe. HA-Fas and E-cadherin from Erd-
mann lab. pCS2 HRS‐RFP was a gift from Edward De Robertis (Addgene plasmid
#29685). pCMV3‐C‐Flag human Dysbindin gene was from Sino Biological Inc.
(HG15072CF). Cells were transfected with DNA using Lipofectamine 2000 (Invi-
trogen) according to the manufacturer’s protocol.
RNA interference and rescue experiments. Allstar negative control siRNA,
Hs_ENTR1_6 (CGACGCACUGAAAGAUGAA), which is siRNA1 and
Hs_ENTR1_7 (ACUGAAUCUUGUUGCCGAA) which is siRNA 2 were from
Qiagen. Pre‐designed ENTR1s21238 (CCACGUCGUGAAACUAAAA), which is
siRNA 3 was from Invitrogen. SiRNA for Dysbindin (CAGCAAAUCUGACUCA
UUU) was from Ambion, Life technologies45 and for Hrs (CGACAAGAACCCAC
ACGUC) from Dharmacon37. PTPN13 siRNA1 (AAGUAAGCCUAGCUGAUCC
UGUU), PTPN13 siRNA2 (CAGAUCAGCUUUCCUGUAAUU) were both from
Dharmacon. For the rescue experiments, ENTR1 constructs were made siRNA
resistant by mutating three consecutive nucleotides with site directed mutagenesis
kit (Quick change II XL by Agilent technologies) according to the manufacturers’
protocol.
Flow cytometry. Cells were detached from the culture dish with trypsin‐EDTA for
5 min and washed once with 1% BSA/PBS and incubated with either Alexa con-
jugated or unconjugated primary antibodies for 1 h at 4 °C. After labelling with
secondary antibody, cells were analysed immediately by BD LSRII™ or BD
FACSCalibur™ ﬂow cytometers (BD Biosciences). Secondary antibody alone was
used as the negative control for determining speciﬁcity of the signal.
Immunoﬂuorescence analysis. Images were acquired using the Perkin Elmer
Ultraview VoX spinning disc confocal microscope and Olympus epiﬂuorescence
microscope. Superresolution microscopy was performed using Deltavision/GE
OMX optical microscope for structured illumination (3D‐SIM). Co‐localisation
analysis was performed on confocal sections showing maximum intensity for
Lamp‐1 or EEA‐1 and Fas antigens using JACoP plugin in Image J software.
Threshold levels were adjusted uniformly across the conditions to reduce back-
ground noise from the analysis. Occurrence of co‐localisation was calculated using
Pearson’s correlation coefﬁcient (PCC) and quantiﬁcation of the colocalisation was
obtained using overlap coefﬁcients (k1 and k2). Endosomal lumen localisation was
analysed following established protocols [34]. A straight line was drawn across the
diameter of each enlarged endosome. Intensity was normalised to account for
varying endosome sizes. Luminal membrane was visualised via Rab5 Q79L-GFP,
Fas was visualised via anti-Fas antibody. The ﬁrst and second maximum peaks of
the GFP ﬂuorescence were marked as 0 and 100 respectively representing the
luminal membrane boundaries. Middle ﬂuorescence values (40–60) for Fas were
calculated from raw pixel intensities obtained from line scale analysis using
Image J.
Protein interaction experiments and immunoblotting. For GFP-Trap pulldown,
cells were lysed in lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1.5 mM
MgCl2, 1 mM EDTA, 10% glycerol, 1% Triton X-100). Cell lysates were incubated
for 3 h with GFP-Trap®_A at 4 °C. After three washing steps with lysis buffer,
bound proteins were eluted in Laemmli buffer at 95 °C and separated by
SDS–PAGE. Proteins were transferred onto nitrocellulose membrane, incubated
with the relevant antibodies and detected using the Odyssey Sa Infrared Imaging
System (LI-COR Biosciences, Ltd, UK). Uncropped images of all western-blots
displayed in this study are provided as supplementary Fig. 11.
GST pull-down assay. Lysates were obtained from 60 mm conﬂuent dishes of
HeLa cells and 10% of the pre-cleared protein extract was used as input repre-
senting total protein levels. The remaining cell lysate was added to 50 μl of GST
fusion protein or GST control beads slurry and incubated for 4 h at 4 °C and
constant mixing. After incubation, samples were spun at 6030 g for 2 min at 4 °C.
Beads were washed ﬁve times with 500 μl of cold 0.5% Triton X-100 in PBS by
centrifuging at 6030 g for 2 min between each of the washing steps. Finally, pro-
teins were eluted from the beads by adding 2x Laemmli buffer followed by heating
at 95 °C for 5 min. Proteins were loaded on 10% acrylamide gels and separated by
SDS-PAGE.
Generation of ENTR1 knock-out cell lines. Guide RNAs were designed with
CRISPOR online tool providing the target sequence of ENTR1. For ENTR1 gRNA
design exon 4 was targeted as targeting exons 1 and 2 would not affect ENTR1
isoform 3 (information obtained from UNIPROT). gRNA sequence included 4
nucleotides overhangs compatible with desired vectors and a PAM motif. gRNAs
were cloned in px458-GFP vector67. Cells were transfected with 2 μg of px458-GFP
plasmid containing gRNA for ENTR1. After 48 h, cells were trypsinised, re-
suspended in 1 mL of DMEM supplemented with 10% FBS and centrifuged at 94 g
for 5 min. Supernatant was removed and cells were re-suspended in 500 μl of Opti-
MEM. Cell suspension was transferred to ﬂow cytometry tubes and kept on ice.
Sorting of GFP positive single cells into 96-well plates was performed with BD
FASC Aria Ilu (Flow cytometry Core Facility, The University of Shefﬁeld). Sorted
single cells were incubated in 96-well plates and screened for colonies after
2–3 weeks. Colonies generated from single cells were sequentially expanded. At this
point, genomic DNA was extracted and region of interest was ampliﬁed using
ENTR1 speciﬁc primers (forward primer GCCACACTCATGCACGATTC, reverse
primer TCAGCCACCTTCACACTTCC). Western blot analysis was then used to
screen for positive knock-out clones. Positive ENTR1 knock-out clones were
subsequently expanded into 10 cm dishes and used for further experiments.
Apoptosis assay monitored by cleaved Caspase 3. HeLa cells were seeded on
coverslips in 12-well plates at the appropriate cell density and 24 h later transfected
with either control or ENTR1/Dysbindin/HRS siRNA. Upon 72-h incubation cells
were treated with CH11 (500 ng/mL) or SuperFas soluble ligand (0.5 μg/mL) and
cycloheximide (50 μg/mL) in DMEM medium supplemented with 10% FBS for 2 h.
Cells were subsequently ﬁxed with 4% PFA and standard immunoﬂuorescence
protocol was performed using anti-cleaved Caspase 3 (Asp175, Cell Signalling).
Finally, coverslips were imaged in Motorised Olympus BX61 Epiﬂuorescence
microscope by taking ten random pictures of 20x magniﬁcation from every con-
dition. Quantiﬁcation was based on the percentage of positive cells for cleaved
Caspase 3 (representing apoptotic cells) with respect to the total number of cells.
Cell surface biotinylation. Cells were cultured on 60 mm dishes incubated with
EZ‐Link Sulfo‐NHS‐SSBiotin (Thermo Fisher Scientiﬁc) at a concentration
0.25 mg/ml in ice cold PBS. Cells were washed with 1% BSA/PBS to quench any
unbound biotin and lysed with 1% Triton X‐100 in PBS supplemented with pro-
tease cocktail inhibitors (Roche) to pull down biotinylated proteins with Neu-
trAvidin agarose beads (Thermo Fisher scientiﬁc).
Endocytosis assay. HeLa cells were treated with control or ENTR1 siRNAs for
72 h. Cells were harvested using trypsin-EDTA. Only surface population of Fas
receptors was labelled using 1 μg/ml of Anti-Fas CH-11 antibody in ice-cold 1%
BSA/PBS solution for 1 h at 4 °C with constant rotation. Unbound primary anti-
body was removed by washing the cells three times with 1% cold BSA/PBS at 166xg
for 2 min. Washed cells were resuspended in pre-warmed DMEM media and
incubated at 37 °C for various time points. At the end of each time point, endo-
cytosis was stopped by incubating the cells on ice. Cells were labelled with Alexa
488 conjugated secondary antibody for 1 h at 4 °C with constant rotation and
washed thrice to remove any unbound labelling antibody. Samples were analysed
immediately using BD LSR II Flow cytometer or BD FACSCalibur™. Unstained and
secondary only labelled HeLa cells were also analysed as negative controls.
Endogenous Fas degradation assay. HCT-116 wild-type and HCT-116 ENTR1
knock-out (clone 4) cells were seeded in 6-well plates and incubated until conﬂuence
was reached. Cells were treated with Fas CH11 agonistic antibody (500 ng/mL) and
cycloheximide (150 μg/mL) diluted in DMEM medium supplemented with 10%
FBS at different time points ranging from 0 to 2 h. After induction of Fas-mediated
apoptosis, cells were lysed with 1% Triton in 1x PBS lysis buffer plus protease
cocktail inhibitor (Roche). Protein concentration was equalised in all samples. 4x
Laemmli buffer was added to protein extracts and samples were boiled at 95 °C for
5 min and subsequently analysed by western blotting. Immunoblotting for β-
tubulin was used as a loading control and transferrin receptor as a control for cell
surface receptor, which is not affected by Fas stimulation.
Blocking recycling. HeLa cells were co-transfected with ENTR1 siRNA and either
Rab11 wt-GFP, Rab 11 DN-GFP, Rab4a wt-GFP, Rab4a DN-GFP or RBD-GFP
(Rab-binding domain of the Rab coupling protein). 72 h post-transfection, cells
were labelled as described above and Fas cell surface expression was measured with
the LSRII ﬂow cytometer.
Mapping of caspase cleavage site and caspase inhibitor assay. ENTR1 protein
sequence was manually screened for potential cleavage sites resembling other
known caspase cleavage sites52. In total ﬁve potential sites were further investigated
and the conserved aspartate in each oft he sites was mutated to alanine. HeLa cells
were transfected with double-tagged wild-type ENTR1 or with individual cleavage
site mutant constructs and twenty-four hours post-transfection, cells were treated
with 200 ng/ml CH11 and 2.5 µg/ml cycloheximide for 3 h at 37 °C, then lysed in
NETN-buffer (100 mM NaCl, 20 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 0.5% NP-
40). Total protein concentration was determined using DCTM Protein Assay (Bio-
Rad Laboratories, Inc.), protein samples were analysed by western blotting to assess
cleavage of ENTR1. For the caspase inhibitor assays HeLa cells were transfected
with a double-tagged wild-type ENTR1 expression construct. Twenty hours post-
transfection, cells were pre-treated with 5.0 µM of the corresponding caspase
speciﬁc inhibitors for 1 h at 37 °C and subsequently with 200 ng/ml CH11 and
2.5 µg/ml cycloheximide for 3 h at 37 °C. Further procedure was as described for
mapping of the caspase cleavage site.
For mass spectrometry analysis HeLa cells were transfected with Myc-ENTR1-
Flag expression construct. 48 h after transfection cells were stimulated with anti-
CH11 for 3 h, cells were lysed and lysates were subjected to anti-Flag
immunoprecipitation using anti-Flag agarose. Bound proteins were washed and
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eluted with Flag peptide. Eluted proteins were separated by SDS-gel electrophoresis
and stained with Coomassie Blue. The 27 kDa band was excised and in-gel
digestion was performed as reported previously68. Extracted peptides were analysed
by nanoﬂow LC-MS/MS using an Orbitrap Elite (Thermo Fisher) hybrid mass
spectrometer equipped with a nanospray source, coupled to an Ultimate RSLCnano
LC System (Dionex). The system was controlled by Xcalibur 2.1 (Thermo Fisher)
and DCMSLink 2.08 (Dionex). Peptides were desalted on-line using a micro-
Precolumn cartridge (C18 Pepmap 100, LC Packings) and then separated using a
40 min RP gradient (4–32% acetonitrile/0.1% formic acid) on an EASY-Spray
column, 15 cm × 50 µm ID, PepMap C18, 2 µm particles, 100 Å pore size (Thermo).
The LTQ-Orbitrap Elite was operated with a cycle of one MS (in the Orbitrap)
acquired at a resolution of 60,000 at m/z 400, with the top 20 most abundant
multiply-charged (2+ and higher) ions in a given chromatographic window
subjected to MS/MS fragmentation in the linear ion trap. An FTMS target values of
1e6 and an ion trap MSn target value of 1e4 was used and with the lock mass
(445.120025) enabled. Maximum FTMS scan accumulation time of 500 ms and
maximum ion trap MSn scan accumulation time of 100 ms were used. Dynamic
exclusion was enabled with a repeat duration of 45 s with an exclusion list of 500
and exclusion duration of 30 s. MS data was analysed data using MaxQuant version
1.6.0.1669. Data was searched against a human UniProt sequence databases
(downloaded June 2015) using following search parameters: trypsin/AspC in semi
speciﬁc mode, 7 ppm for MS mass tolerance, 0.5 Da for MS/MS mass tolerance,
with Acetyl (Protein N-term), Oxidation (M), carbamidomethyl (C) and Phospho
(STY) set as variable modiﬁcations. A protein FDR of 0.01 and a peptide FDR of
0.01 were used for identiﬁcation level cut offs.
Immunohistochemistry for colon cancer tissue microarrays. Parafﬁn-embedded
tissue arrays were acquired from US Biomax (CO242b). First, tissue array was
deparafﬁnised by immersing slides twice in xylene for 10 min, followed by
immersions in 100, 95 and 70% of ethanol 5 min each. Slides were immersed in
water and rinsed twice in 1x PBS for 5 min. In order to inactivate endogenous
peroxidase activity, slides were incubated for 20 min with 3% H2O2. After 5 min
wash in 1x PBS, antigen retrieval was carried out by cooking slides for 10 min in
the microwave, immersed in Na-Citrate buffer. Next, tissue array was stained
according to Vectastain ABC Elite Universal kit (Vector labs) manufacturer’s
protocol and subsequently incubated in peroxidase substrate (ImmPACT DAB
chromogen) until the desired stain intensity was developed. Reaction was stopped
and ﬁnally, slides were transferred into 95% ethanol (2 changes for 2 min each),
100% ethanol (2 changes for 2 min each) and xylene (3 changes for 5 min each) to
dehydrate and clear slides. Excess of solutions was drained from slides and dried
for 10 min. Coverslips were mounted in Vectamount (non-aqueous mounting
medium) and dried for at least 24 h. The imaging and analysis of the tissue
microarrays was performed at the Shefﬁeld Institute for Translational Neuroscience
(SITraN). Slide scanner NanoZoomerXR was used for the imaging and the software
used to analyse the cores was Visiopharm.
Statistical analysis. Prism (Graph Pad software) was used to analyse data
obtained from multiple independent experiments. The statistical signiﬁcance was
tested using student t‐test between two groups or analysis of variance (ANOVA)
between more than two groups. Multiple comparisons procedures were applied as
and when required. Correlation statistical analysis were performed by using
Pearson R test and Mander’s overlap coefﬁcient R was used to quantify
co-localisation.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the ﬁndings of this study are available from the corresponding
author upon reasonable request.
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